Status Epilepticus Clinical Trial
Official title:
A Multi-center Clinical Study of Children With Status Epilepticus in China
Phase 1: The first part of study is a multi-center, retrospect study involving 38 hospitals.
The program is a national epidemiological study on status epilepticus in Chinese children.The
aims of the epidemiological study include:
1. to obtain national epidemiological data on the etiology, diagnosis,treatment,evaluation,
risk factors , outcome and analyze the burden of disease.
2. to build a Collaborative Network in pediatric status epilepticus research.
3. to establish a national clinical database of pediatric status epilepticus.
4. to lay the foundation for the further prospective study.
Phase 2: The second part of study is a multi-center, prospective study involving 38
hospitals. The aim of the study is to set up guideline of Children with SE in China.
Status | Recruiting |
Enrollment | 6000 |
Est. completion date | September 2019 |
Est. primary completion date | September 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 18 Years |
Eligibility |
Inclusion Criteria: 1. Patients who meet the diagnosis of Status Epilepticus(SE),which is defined as more than 30 minutes of either1).continuous seizure activity or 2).two or more sequential seizures without full recovery of consciousness between seizures, including Status Epilepticus (CSE) and Nonconvulsive Status Epilepticus(NCSE). 2. The age range: 29 days to <18years 3. Cases with complete clinical information. 4. Inpatient. All cases those meet full of the above 4 criterias are included in our study. Exclusion Criteria: 1. A seizure less than 30 minutes 2. The newborn and more than 18 years old. |
Country | Name | City | State |
---|---|---|---|
China | Beijing Children's Hospital | Beijing | Beijing |
Lead Sponsor | Collaborator |
---|---|
Fudan University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The outcome of children with SE at discharge | Use four measures to evaluate the outcome at discharge 1. Normal 2. With dysfunction 3. With secondary epilepsy 4. Death | 2016.10.1-2017.6.30 | |
Secondary | Glasgow Outcome Scale(GOS) | The GOS is a prognostic assessment tool for children with SE. GOS Score =1death GOS Score=2 Vegetative state ,Unable to interact with environment; unresponsive; GOS Score=3 Severe disability, Able to follow commands/ unable to live independently ;GOS Score=4 Moderate disability, Able to live independently; unable to return to work or school ;GOS Score=5 Good recovery,Able to return to work or school | 2016.10.1-2017.6.30 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03883516 -
Improving Emergency Management of Status Epilepticus
|
N/A | |
Recruiting |
NCT00362141 -
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus
|
Phase 2 | |
Recruiting |
NCT05140265 -
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
|
||
Active, not recruiting |
NCT04391569 -
Randomized Therapy In Status Epilepticus
|
Phase 3 | |
Recruiting |
NCT06017973 -
The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus
|
N/A | |
Completed |
NCT06334796 -
Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology
|
Early Phase 1 | |
Recruiting |
NCT05491590 -
Patient-reported Outcome After Status Epilepticus
|
||
Recruiting |
NCT04421846 -
Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
|
N/A | |
Completed |
NCT02958605 -
Smartphone Apps for Pediatric Resuscitation
|
N/A | |
Completed |
NCT02239380 -
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
|
Phase 3 | |
Completed |
NCT01796574 -
Ketogenic Diet for Refractory Status Epilepticus
|
N/A | |
Completed |
NCT02381977 -
Prevalence of Acute Critical Neurological Disease in Children: a Global Epidemiological Assessment
|
N/A | |
Completed |
NCT00004297 -
Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus
|
Phase 3 | |
Completed |
NCT03905798 -
LORA-PITA IV General Investigation
|
||
Recruiting |
NCT05591508 -
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
|
N/A | |
Completed |
NCT00735527 -
Nasal Versus Venous Lorazepam for Control of Acute Seizures in Children
|
Phase 3 | |
Terminated |
NCT00265616 -
Treatment of Refractory Status Epilepticus
|
Phase 3 | |
Recruiting |
NCT06401707 -
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
|
Phase 2 | |
Enrolling by invitation |
NCT06403150 -
The Efficacy and Safety of Levetiracetam Versus Fosphenytoin in Convulsive Status Epilepticus
|
Phase 4 | |
Recruiting |
NCT05246566 -
Assessment of Adults Epidemiological Characteristics of Status Epilepticus in the French West Indies and in French Guiana
|